IBDEI2SS ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46964,2)
 ;;=^5007825
 ;;^UTILITY(U,$J,358.3,46965,0)
 ;;=I80.211^^206^2316^16
 ;;^UTILITY(U,$J,358.3,46965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46965,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Right Iliac Vein
 ;;^UTILITY(U,$J,358.3,46965,1,4,0)
 ;;=4^I80.211
 ;;^UTILITY(U,$J,358.3,46965,2)
 ;;=^5007831
 ;;^UTILITY(U,$J,358.3,46966,0)
 ;;=I80.221^^206^2316^19
 ;;^UTILITY(U,$J,358.3,46966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46966,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Right Popliteal Vein
 ;;^UTILITY(U,$J,358.3,46966,1,4,0)
 ;;=4^I80.221
 ;;^UTILITY(U,$J,358.3,46966,2)
 ;;=^5007835
 ;;^UTILITY(U,$J,358.3,46967,0)
 ;;=I80.231^^206^2316^20
 ;;^UTILITY(U,$J,358.3,46967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46967,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Right Tibial Vein
 ;;^UTILITY(U,$J,358.3,46967,1,4,0)
 ;;=4^I80.231
 ;;^UTILITY(U,$J,358.3,46967,2)
 ;;=^5007839
 ;;^UTILITY(U,$J,358.3,46968,0)
 ;;=I80.03^^206^2316^6
 ;;^UTILITY(U,$J,358.3,46968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46968,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Lower Extremity Superfic Vessels
 ;;^UTILITY(U,$J,358.3,46968,1,4,0)
 ;;=4^I80.03
 ;;^UTILITY(U,$J,358.3,46968,2)
 ;;=^5007823
 ;;^UTILITY(U,$J,358.3,46969,0)
 ;;=I80.02^^206^2316^12
 ;;^UTILITY(U,$J,358.3,46969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46969,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Left Lower Extremity Superfic Vessels
 ;;^UTILITY(U,$J,358.3,46969,1,4,0)
 ;;=4^I80.02
 ;;^UTILITY(U,$J,358.3,46969,2)
 ;;=^5007822
 ;;^UTILITY(U,$J,358.3,46970,0)
 ;;=I80.01^^206^2316^18
 ;;^UTILITY(U,$J,358.3,46970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46970,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Right Lower Extremity Superfic Vessels
 ;;^UTILITY(U,$J,358.3,46970,1,4,0)
 ;;=4^I80.01
 ;;^UTILITY(U,$J,358.3,46970,2)
 ;;=^5007821
 ;;^UTILITY(U,$J,358.3,46971,0)
 ;;=I80.9^^206^2316^21
 ;;^UTILITY(U,$J,358.3,46971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46971,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Unspec Site
 ;;^UTILITY(U,$J,358.3,46971,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,46971,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,46972,0)
 ;;=R91.8^^206^2317^2
 ;;^UTILITY(U,$J,358.3,46972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46972,1,3,0)
 ;;=3^Abnormal Lung Field Findings
 ;;^UTILITY(U,$J,358.3,46972,1,4,0)
 ;;=4^R91.8
 ;;^UTILITY(U,$J,358.3,46972,2)
 ;;=^5019708
 ;;^UTILITY(U,$J,358.3,46973,0)
 ;;=R63.4^^206^2317^3
 ;;^UTILITY(U,$J,358.3,46973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46973,1,3,0)
 ;;=3^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,46973,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,46973,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,46974,0)
 ;;=R10.0^^206^2317^4
 ;;^UTILITY(U,$J,358.3,46974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46974,1,3,0)
 ;;=3^Acute Abdomen
 ;;^UTILITY(U,$J,358.3,46974,1,4,0)
 ;;=4^R10.0
 ;;^UTILITY(U,$J,358.3,46974,2)
 ;;=^885
 ;;^UTILITY(U,$J,358.3,46975,0)
 ;;=M80.08XA^^206^2317^58
 ;;^UTILITY(U,$J,358.3,46975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46975,1,3,0)
 ;;=3^Osteoporosis,Age-Related w/ Vertebra Fx,Init Encntr
 ;;^UTILITY(U,$J,358.3,46975,1,4,0)
 ;;=4^M80.08XA
 ;;^UTILITY(U,$J,358.3,46975,2)
 ;;=^5013495
 ;;^UTILITY(U,$J,358.3,46976,0)
 ;;=K52.2^^206^2317^5
 ;;^UTILITY(U,$J,358.3,46976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46976,1,3,0)
 ;;=3^Allergic/Dietetic Gastroenteritis/Colitis
 ;;^UTILITY(U,$J,358.3,46976,1,4,0)
 ;;=4^K52.2
 ;;^UTILITY(U,$J,358.3,46976,2)
 ;;=^5008701
 ;;^UTILITY(U,$J,358.3,46977,0)
 ;;=R63.0^^206^2317^6
 ;;^UTILITY(U,$J,358.3,46977,1,0)
 ;;=^358.31IA^4^2
